QualityStocksNewsBreaks Archives - Page 596 of 1498

WednesdayDec 01, 2021 2:00 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Deconsolidate BIGtoken Inc. (FPVD) Following Merger

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has announced that, from this date forward, it will no longer have to consolidate the financials of BIGtoken (OTC: FPVD). On Sept. 27, 2021, BIGtoken, the leading platform for ethically-sourced identity, data and insights creation and media activation, and BritePool Inc., a leading identity verification company for advertisers and publishers, entered into an agreement and plan of merger in an all-stock transaction. Upon completion of the union, SRAX is no longer obligated to consolidate BIGtoken into its financials.…

WednesdayDec 01, 2021 10:48 am

QualityStocksNewsBreaks – LQwD Fintech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Featured in Latest Episode of ‘Bell2Bell’ Podcast

LQwD Fintech (TSX.V: LQWD) (OTCQB: LQWDF), a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption, was featured in the “Bell2Bell Podcast,” a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. LQwD’s co-founder, chairman and CEO Shone Anstey joined the latest episode to discuss LQwD’s business model and his proven track record in the fast-moving cryptocurrency sector. “We are known as a Lightning Network service provider, or a liquidity service provider. We have a platform-as-a-service, which you can look up on our website. There, you can go in and create a Lightning Network node…

WednesdayDec 01, 2021 10:06 am

QualityStocksNewsBreaks – Lottery.com (NASDAQ: LTRY) Names New Global VP of Affiliate Success

Lottery.com (NASDAQ: LTRY, LTRYW), a leading technology company that is transforming how, where and when the lottery is played, has appointed marketing veteran Greg Potts as its new global vice president of affiliate success. With more than two decades of strategic marketing experience, Potts has developed growth strategies for numerous consumer brands through targeted marketing efforts using co-op funding mechanisms. In his new position with Lottery.com, he will oversee the company’s business-to-business (“B2B”) growth strategy as well as its new Global Affiliate Marketing Program, which aims to add master affiliates and sub-affiliates while providing them with tools to accelerate the…

TuesdayNov 30, 2021 3:11 pm

QualityStocksNewsBreaks – Tingo Inc. (IWBB) Ranking Amongst Rarest of Companies

Tingo (OTCQB: IWBB) recently applied to list its shares for trading with the New York Stock Exchange (“NYSE”), forming part of efforts to broaden its appeal to U.S. and international investors. Although there are no guarantees that its listing application will be accepted, the company has reiterated its belief that it will satisfy the NYSE’s initial listing criteria. A recent article quotes Tingo CEO Dozy Mmobuosi as saying: “The NYSE is the main stock exchange in the United States and one that will raise our profile to the broader investment community. The bottom-up list will increase liquidity in our stocks…

TuesdayNov 30, 2021 2:06 pm

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Q3 2021 Report Showing 1,000% Increase in Revenues

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has released its unaudited financial results for the quarter ended Sept. 30, 2021; all numbers are in Canadian dollars. Among the highlights include a revenue growth figure of $1.1 million, which represents more than a 1,000% increase over the $94,000 reported in the same quarter last year. In addition, the company noted gross profit of $356,168 during Q3 2021, compared to a loss of $40,280 for Q3 2020. BevCanna closed the quarter with cash reserves of $655,563. Business highlights include a…

TuesdayNov 30, 2021 1:55 pm

QualityStocksNewsBreaks – Asia Broadband Inc. (AABB) Enters Definitive Acquisition Agreement for High-Grade Bonanza Gold Mine Project

Asia Broadband (OTC: AABB) today announced its entry into a definitive purchase agreement to acquire a 100% interest in the Bonanza Gold Mine Project. According to the update, the company came to terms with Martin Augusto Vallejo Lujambio for the 19.25-hectare concession # 221977, Bonanza, located approximately 48 kms southeast from the city of Acaponeta and 3 kms from the town of El Carrizo, in Nayarit, Mexico. The property’s total purchase price was $6 million, split into $ 2 million cash and $ 4 million in restricted shares of Asia Broadband. The project is another prospective high-yield asset addition in…

TuesdayNov 30, 2021 1:39 pm

QualityStocksNewsBreaks – Lottery.com (NASDAQ: LTRY) Announces Participation in Sports Betting, iGaming Summit

Lottery.com (NASDAQ: LTRY, LTRYW), a leading technology company that is transforming how, where and when the lottery is played, will be participating in the upcoming Jefferies Sports Betting and iGaming Summit. The summit, scheduled to take place on Dec. 2, 2021, will include a fireside chat, which will include Lottery.com cofounder and CEO Tony DiMatteo. The chat will begin at 4 p.m. ET. In addition, DiMatteo will be available to meet with conference attendees. An archived replay of DiMatteo’s presentation will be available for 30 days. Lottery.com is dedicated offering mobile and online platforms that support players and commercial globally…

TuesdayNov 30, 2021 1:05 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Key FDA Approvals, Participation in Psychedelics Conference

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has received authorization from the U.S. Food and Drug Administration (“FDA”) for an investigator-initiated, randomized, placebo-controlled phase 2 clinical trial; the trial is designed to evaluate psychedelic-assisted psychotherapy with psilocybin for frontline clinicians experiencing COVID-related distress. The company noted that the primary investigator for the trial, Dr. Anthony Back, received an investigational new drug ("IND") approval letter from the FDA, authorizing the trial. In addition, the study has received Institutional Review Board (“IRB”) approval at the University of Washington. Cybin also announced that CEO Doug Drysdale…

TuesdayNov 30, 2021 12:10 pm

QualityStocksNewsBreaks– Nemaura Medical Inc. (NASDAQ: NMRD) CEO to Present at Benzinga Global Small Cap Conference

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced that its CEO Faz Chowdhury, Ph.D., will present at the Benzinga Global Small Cap Conference. The event is scheduled to be held virtually from Dec. 8-9, 2021. Dr. Chowdhury will deliver his corporate presentation at 3:00 p.m. ET on Dec. 8 and will be available for one-on-one meetings throughout the conference. Interested parties should visit https://ibn.fm/puHmj to register for the event. To view the full press release, visit https://ibn.fm/RJcQX About Nemaura Medical Inc. Nemaura Medical…

TuesdayNov 30, 2021 11:37 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Strategy Toward Potential Therapeutics for Diseases with High Unmet Needs

InMed Pharmaceuticals (NASDAQ: INM) recently filed a Patent Cooperation Treaty (“PCT”) application, which specifies a rare cannabinoid (new to InMed’s portfolio) that may inhibit or slow the progression of neurogenerative diseases – such as Alzheimer’s, Parkinson’s, Huntington’s and others – by providing protection in a population of affected neurons. Furthermore, the application demonstrates the cannabinoid can also be used to promote neurite outgrowth, signifying the potential to enhance neuronal function. According to InMed’s Senior VP Pre-Clinical Research & Development Dr. Eric Hsu, who is quoted in a recent article, “This PCT patent application advances our strategy directed towards researching and…

Site Search

Company Search

Category: QualityStocksNewsBreaks